Market revenue in 2023 | USD 4.2 million |
Market revenue in 2030 | USD 11.0 million |
Growth rate | 14.8% (CAGR from 2023 to 2030) |
Largest segment | Product |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Product, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Qiagen NV, Abcam PLC, Takara Bio Inc, Revvity Inc, Maravai LifeSciences Holdings Inc Ordinary Shares - Class A, HTG Molecular Diagnostics Inc, Meridian Bioscience, New England Biolabs, Norgen Biotek, System Biosciences, Amoy Diagnostics, EntroGen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mirna sequencing and assay market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 80.95% in 2023. Horizon Databook has segmented the South Korea mirna sequencing and assay market based on product, services covering the revenue growth of each sub-segment from 2018 to 2030.
The government of South Africa has made basic healthcare reforms by providing technologically advanced products to researchers from the research & development departments to identify the sources of various disease outbreaks in the country and, thus, decrease the mortality rate & increase life expectancy.
In addition, with presence of sequencing service providers, growing operations of key players through subsidiaries, and existence of organizations such as the KRISP–Kwazulu-Natal Research Innovation and Sequencing Platform, the market is expected to grow in the country. KRISP provides support and training to scientists related to advance sequencing techniques.
KRISP has been created by the coordinated effort of the University of KwaZulu-Natal (UKZN), the Technology Innovation Agency (TIA), and the South African Medical Research Council (SAM RC). Thus, the country is expected to witness positive growth over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea mirna sequencing and assay market , including forecasts for subscribers. This country databook contains high-level insights into South Korea mirna sequencing and assay market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account